No decrease in fracture risk despite 15 years of treatment evolution for multiple myeloma patients: A Danish nationwide case-control study

Berdien E Oortgiesen, Johanna H M Driessen, Mels Hoogendoorn, Robby E Kibbelaar, Nic J G M Veeger, Joop P W van den Bergh, Peter Vestergaard, Frank de Vries, Eric N van Roon

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number115299
Number of pages6
JournalBone
Volume134
Early online date22 Feb 2020
DOIs
Publication statusPublished - May 2020

Keywords

  • Case-control
  • DIAGNOSIS
  • Fracture risk
  • LENALIDOMIDE
  • MANAGEMENT
  • MONOCLONAL GAMMOPATHY
  • Multiple myeloma
  • OUTCOMES
  • SURVIVAL
  • Treatment strategy
  • VERTEBRAL FRACTURES

Cite this